FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA is processing a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals, related to a labeling update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

SUPPL AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)